发明名称 TREATMENT OF NEUROLOGICAL DISORDERS
摘要 This invention provides treatment compositions as well as systems and methods of determining and administering an effective amount of treatment for a neurological disorder. The treatment composition can contain a labeled interfering RNA (iRNA) agent capable of decreasing expression of a target RNA associated with the neurological disorder. The methods of the invention include determining an effective amount of a therapeutic composition by introducing a solution containing a tracer into the brain of a mammal. The tracing solution is monitored until a target volume of distribution at steady state distribution is substantially achieved, and the rate of delivery of the therapeutic composition is determined. The therapeutic composition can then be administered at the rate determined by use of the tracing solution.
申请公布号 US2012116360(A1) 申请公布日期 2012.05.10
申请号 US201013383560 申请日期 2010.07.15
申请人 SAH DINAH W. Y.;GUZAEV ANDREI P.;ADAMS MATTHEW H.;GE PEI;MANOHARAN MUTHIAH;GWOST DOUGLAS ULEN;STEWART GREGORY ROBERT;STILES DAVID KENT;NELSON BRIAN DALE;KAEMMERER WILLIAM FREDERICK;GASH DON MARSHALL;ALNYLAM PHARMACEUTICALS, INC.;MEDTRONIC, INC. 发明人 SAH DINAH W. Y.;GUZAEV ANDREI P.;ADAMS MATTHEW H.;GE PEI;MANOHARAN MUTHIAH;GWOST DOUGLAS ULEN;STEWART GREGORY ROBERT;STILES DAVID KENT;NELSON BRIAN DALE;KAEMMERER WILLIAM FREDERICK;GASH DON MARSHALL
分类号 A61M5/168;A61K31/7088;A61K49/00;A61M5/142 主分类号 A61M5/168
代理机构 代理人
主权项
地址